ArticleJournal for immunotherapy of cancer2024

Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors.

Sara Feola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.